Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.
MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.
Curve develops an innovative screening platform.
NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.
Vivet Therapeutics is a biotechnology company developing gene therapy treatments for orphan diseases.
Arkuda Therapeutics is a pharmaceutical company.
EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.
CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.
Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases.
GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Superfluid Dx is a biotechnology company developing novel blood-based early detection.
FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.
Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.
Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.
Kestrel Therapeutics is a medical research and devenlopment company that offers treatment solutions for RAS cancers.
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
A decentralized collective funding early stage aging research & spinning out longevity biotech startups to extend healthy lifespan
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs.
Ervaxx is illuminating the immune interface to develop new cancer therapies.
Agomab is a biotechnology company developing therapies that maintains and restores organ function in diseases characterized by fibrosis.
Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.
HealthTech Innovations is a spin-off of Hospital Germans Trias i Pujol and transforming medical care through virtual reality.
Syneron is a company that using artificial intelligence and biotechnology to address two significant global challenges.
Pfizer has invested in 100 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Pfizer's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Biopharma. The firm invests across 18 different industry categories.
Among tracked funding rounds, Cerevel Therapeutics received $450.0M in a Post-IPO Equity round. Pfizer's total known invested capital is $4.0B.
Pfizer's average investment size is $92.6M across its portfolio of 100 companies.
Recent Pfizer portfolio additions include Flare Therapeutics, MindImmune Therapeutics, Curve Therapeutics, NexImmune, Vivet Therapeutics. These companies were founded in 2020 or later.